Browsing: Malignancies

In honor of Brain Tumor Awareness Month in May, RadOnc on the Run host Brandon Mancini, MD, MBA, FACRO, discussed…

In an interview with CancerNetwork®, Naomi Cazeau, MSN, ANP-BC, AOCNP, nurse practitioner at Memorial Sloan Kettering Cancer Center, highlighted the intricate psychoneurological (PN) symptom…

The FDA has approved ruxolitinib extended-release tablets (Jakafi XR) as a treatment for adults with intermediate- or high-risk myelofibrosis, adults…

Following the 2026 National ICE-T Conference in Charlotte, North Carolina, CancerNetwork® spoke with conference director Zahra Mahmoudjafari, PharmD, MBA, BCOP,…

The FDA has extended its review period for a biologics license application (BLA) seeking approval for Orca-T as a treatment…

In October 2025, the FDA granted priority review to Orca-T, a novel allogenic T-cell immunotherapy, for the treatment of multiple…